Status:
RECRUITING
Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer
Lead Sponsor:
Mayo Clinic
Conditions:
Breast Carcinoma
Metastatic Breast Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
This study is being done to create a resource of samples and information that can be used to improve our understanding of the development, progression and treatment of recurrent or metastatic breast c...
Detailed Description
PRIMARY OBJECTIVE: I. To collect blood samples and fresh tissue from biopsies of metastatic lesions from Mayo Clinic patients with metastatic breast cancer. OUTLINE: This is an observational study. ...
Eligibility Criteria
Inclusion
- Female participants must have histologically or cytologically confirmed invasive breast cancer.
- Male participants must have biopsy proven breast cancer.
- Age must be \>= 18 years, and all must be able to understand and willing to sign an informed consent document.
Exclusion
- Dementia, altered mental status, or any psychiatric condition that would prohibit the understanding or rendering of informed consent; a history of serious or life-threatening allergic reaction to local anesthetics (i.e. lidocaine, xylocaine).
- Any other condition, which in the opinion of the patient's treating oncologist, or the physician performing the biopsy procedure, would make participation in this protocol unreasonably hazardous for the patient.
Key Trial Info
Start Date :
June 5 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2034
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06217874
Start Date
June 5 2014
End Date
June 30 2034
Last Update
September 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905